In the News November 21, 2018

Law360 | FDA Finally Hitting Sweet Spot with Off-Label Oversight

Marc Scheineson comments on off-label oversight by the U.S. Food and Drug Administration.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement